Asahi Kasei Corporate Venture Capital

Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy.

Rege Nephro is a biotech company specializing in R&D, production, and marketing of renal disease therapeutics. It utilizes induced pluripotent stem cell (iPSC)-based technology from the Center for iPS Cell Research and Application (CiRA), Kyoto University. It is developing therapeutics and cell therapy for kidney, liver, and pancreas diseases.

Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings.

Hazel Technologies develops biotechnology for reducing waste in the agricultural supply chain. Their product development is funded in part by the United States Department of Agriculture (USDA) and their product performance has been validated by 3rd party academic research institutions such as Cornell University. The company provides USDA-funded 1-MCP technology conditions the storage atmosphere to reduce respiration rate & increase resistance to ethylene. Hazel Technologies offers horticultural consulting services to growers and shippers, as well as develops new solutions to reduce food waste to improve the fresh produce supply chain. It also provides shelf-life extension technologies and services to combat the global food waste problem and improve profitability for its customers. Hazel Technologies was founded in 2015 and is headquartered in Chicago, Illinois, USA.

Firework offers video commerce solutions built for websites, apps, and stores. They operate a storytelling platform intended to live stream videos directly on the website. The company's platform features in-video shopping, lead generation, and live streaming events and allows importing and editing videos, enabling brands to engage and convert their website visitors.

Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, and popular science information.

Hazel Technologies develops biotechnology for reducing waste in the agricultural supply chain. Their product development is funded in part by the United States Department of Agriculture (USDA) and their product performance has been validated by 3rd party academic research institutions such as Cornell University. The company provides USDA-funded 1-MCP technology conditions the storage atmosphere to reduce respiration rate & increase resistance to ethylene. Hazel Technologies offers horticultural consulting services to growers and shippers, as well as develops new solutions to reduce food waste to improve the fresh produce supply chain. It also provides shelf-life extension technologies and services to combat the global food waste problem and improve profitability for its customers. Hazel Technologies was founded in 2015 and is headquartered in Chicago, Illinois, USA.

Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.